Browse by Phase
Phase 1 / Phase 2 Clinical Trials
Phase 1/2 combined trials evaluate both safety (Phase 1) and preliminary efficacy (Phase 2) in a single study protocol, often used to accelerate early development.
Total Trials
360
Recruiting Now
360
Top Conditions in Phase 1 / Phase 2
NCT06378190 Phase 1, Phase 2
Recruiting
Treatment of Relapsed or Refractory B-cell Lymphoma With Chimeric Antigen Recept...
Condition
Refractory B-Cell Lymphoma
Enrollment
27 pts
Location
Spain
Sponsor
Instituto de Investigación Bio
NCT06384560 Phase 1, Phase 2
Recruiting
Neoadjuvant Triple Therapy for (Borderline) Resectable Pancreatic Cancer (PREOPA...
Condition
Localized Pancreatic Adenocarcinoma
Enrollment
66 pts
Location
Netherlands
Sponsor
Amsterdam UMC, location VUmc
NCT04550728 Phase 1, Phase 2
Recruiting
Hybrid Robot+FES Stroke Rehabilitation
Condition
Stroke
Enrollment
60 pts
Location
United States
Sponsor
University of Maryland, Baltim
NCT07024407 Phase 1, Phase 2
Recruiting
A Study of Andecaliximab in People With Spinal Cord Injury at Risk for Bone Grow...
Condition
Heterotopic Ossification (HO)
Enrollment
10 pts
Location
United States
Sponsor
Ashibio Inc
NCT07126665 Phase 1, Phase 2
Recruiting
A Study of MHB088C Combined With MHB039A in Patients With Advanced Malignant Sol...
Condition
Advanced Malignant Solid Tumor
Enrollment
116 pts
Location
China
Sponsor
Minghui Pharmaceutical (Hangzh
NCT03556228 Phase 1, Phase 2
Recruiting
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpr...
Condition
Head and Neck Carcinoma
Enrollment
242 pts
Location
United States, Puerto Rico
Sponsor
VM Oncology, LLC
NCT06417411 Phase 1, Phase 2
Recruiting
LEARNER- Low dosE AspiRiN prEterm tRial (Angola)
Condition
Sickle Cell Disease
Enrollment
450 pts
Location
Angola
Sponsor
Instituto Nacional de Investig
NCT04524871 Phase 1, Phase 2
Recruiting
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treat...
Condition
Advanced Liver Cancers
Enrollment
518 pts
Location
United States, China, France
Sponsor
Hoffmann-La Roche
NCT06524609 Phase 1, Phase 2
Recruiting
EGCG for the Prevention and Treatment of TIPN
Condition
Chemotherapy-induced Peripheral Neuropathy
Enrollment
36 pts
Location
China
Sponsor
Han Xi Zhao
NCT05455034 Phase 1, Phase 2
Recruiting
Single-cell Sequencing of BLF to Guide the Treatment of Radiation Pneumonitis or...
Condition
Pneumonitis
Enrollment
40 pts
Location
China
Sponsor
Xinqiao Hospital of Chongqing
NCT05985863 Phase 1, Phase 2
Recruiting
Human Umbilical Cord Mesenchymal Stem Cell Transplantation for The Treatment of ...
Condition
Acute-On-Chronic Liver Failure
Enrollment
150 pts
Location
China
Sponsor
Beijing 302 Hospital
NCT06463522 Phase 1, Phase 2
Recruiting
Safety and Efficacy of Autologous Tumor-infiltrating Lymphocytes Therapy in Pati...
Condition
Hepatocellular Carcinoma
Enrollment
20 pts
Location
China
Sponsor
Beijing 302 Hospital
NCT05933434 Phase 1, Phase 2
Recruiting
Allogenic Mesenchymal Stem Cell Intraarticular Injection for Knee Osteoarthritis...
Condition
Knee Osteoarthritis
Enrollment
80 pts
Location
Denmark
Sponsor
Aarhus University Hospital
NCT05616793 Phase 1, Phase 2
Recruiting
Safety and Tolerability Subretinal OPGx-001 for LCA5-Associated Inherited Retina...
Condition
LCA5
Enrollment
22 pts
Location
United States
Sponsor
Opus Genetics, Inc
NCT05194111 Phase 1, Phase 2
Recruiting
Treating Heart Dysfunction Related to Cancer Therapy With Sacubitril/Valsartan
Condition
Heart Failure
Enrollment
53 pts
Location
United States
Sponsor
Virginia Commonwealth Universi
NCT07243171 Phase 1, Phase 2
Recruiting
A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and ...
Condition
Overweight and/or Obesity
Enrollment
84 pts
Location
China
Sponsor
Hangzhou Sciwind Biosciences C
NCT06869863 Phase 1, Phase 2
Recruiting
Study of Tolerability, Safety, Pharmacokinetics, Pharmacodynamics and Preliminar...
Condition
Azoospermia, Nonobstructive
Enrollment
80 pts
Location
Russia
Sponsor
Lomonosov Moscow State Univers
NCT04337606 Phase 1, Phase 2
Recruiting
Chidamide in Combination With Decitabine in Non-Hodgkin's Lymphoma Relapsed Afte...
Condition
Non Hodgkin Lymphoma
Enrollment
100 pts
Location
China
Sponsor
Chinese PLA General Hospital
NCT04390737 Phase 1, Phase 2
Recruiting
Evaluate the Safety and Clinical Activity of HH2853
Condition
FL Lymphoma
Enrollment
254 pts
Location
United States, China
Sponsor
Haihe Biopharma Co., Ltd.
NCT04459065 Phase 1, Phase 2
Recruiting
Evaluation of IRDye800CW-nimotuzumab in Lung Cancer Surgery
Condition
Lung Cancer
Enrollment
36 pts
Location
Canada
Sponsor
University of Saskatchewan
NCT05086692 Phase 1, Phase 2
Recruiting
A Beta-only IL-2 ImmunoTherapY Study
Condition
Advanced Solid Tumor
Enrollment
115 pts
Location
United States, Australia, Canada
Sponsor
Medicenna Therapeutics, Inc.
NCT03652428 Phase 1, Phase 2
Recruiting
Phase I Nab-Paclitaxel Plus Gemcitabine With Proton Therapy for Locally Advanced...
Condition
Locally Advanced Pancreatic Cancer
Enrollment
24 pts
Location
United States
Sponsor
University of Maryland, Baltim
NCT05608434 Phase 1, Phase 2
Recruiting
Development of Virtual Reality-based Interventions to Strengthen Cognitive Skill...
Condition
Attention Deficit Hyperactivity Disorder
Enrollment
219 pts
Location
United States
Sponsor
National Institute of Mental H
NCT06820164 Phase 1, Phase 2
Recruiting
Lipomas Treated with Subcutaneous Injections of Cooled Sodium Chloride
Condition
Lipoma
Enrollment
20 pts
Location
United States
Sponsor
West Virginia University
NCT05589753 Phase 1, Phase 2
Recruiting
Sleep Disordered Breathing With Opioid Use
Condition
Sleep Apnea
Enrollment
150 pts
Location
United States
Sponsor
VA Office of Research and Deve